IMARC Group’s report titled “Peripheral Artery Disease Market Report by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033”. The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033.
Factors Affecting the Growth of the Peripheral Artery Disease Industry:
-
Aging Population:
PAD is common among older adults. As the population ages, more people face the risk of PAD. This leads to an increase in cases. Consequently, the need for diagnosis and treatment grows. Older adults frequently have risk factors for PAD. These factors include high blood pressure, high cholesterol, diabetes, and a history of smoking. Over time, these issues add up, leading to more PAD cases in this age group.
-
Rising Incidence of Diabetes and Hypertension:
Diabetes and hypertension are major risk factors for PAD. Their increase worldwide directly relates to more PAD cases. Patients with these conditions have a higher risk of PAD because of vascular issues. Both diseases damage blood vessels, causing atherosclerosis. This buildup of plaque in arteries leads to significant vascular damage, a key cause of PAD.
-
Lifestyle Changes:
Many people today lead sedentary lives. They sit for long hours at work and exercise little. This lack of movement raises the risk of Peripheral Artery Disease (PAD). It leads to poor circulation and obesity, among other health problems. Diets high in saturated fats, trans fats, cholesterol, and sodium also matter. These unhealthy foods cause atherosclerosis, where arteries narrow and harden. Atherosclerosis is a key cause of PAD. So, eating unhealthy foods increases the rates of this disease.
Grab a sample PDF of this report: https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample
Leading Companies Operating in the Peripheral Artery Disease Industry:
-
Abbott Laboratories
-
AngioDynamics
-
B. Braun Melsungen AG
-
Becton Dickinson and Company
-
Biotronik SE & Co. KG
-
Boston Scientific Corporation
-
Cardinal Health Inc.
-
Cook Medical LLC
-
Koninklijke Philips N.V.
-
Medtronic plc
-
Terumo Corporation
Peripheral Artery Disease Market Report Segmentation:
By Type:
-
Peripheral Angioplasty Balloons
-
Peripheral Stents
-
Peripheral Catheters
-
Inferior Vena Cava (IVC) Filters
-
Plaque Modification Devices
-
Hemodynamic Flow Alteration Devices
-
Peripheral Accessories
Peripheral stents represent the largest segment. Peripheral stents are widely used for treating arterial blockages in PAD patients, offering effective vascular support and durability compared to other treatment options.
By End User:
-
Hospitals
-
Specialty Clinics
-
Others
Based on the end-user, the market has been divided into hospitals, specialty clinics, and others.
Regional Insights:
-
North America (the United States and Canada)
-
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)
-
Europe (Germany, France, the United Kingdom, Italy, Spain, and others)
-
Latin America (Brazil, Mexico, and others); the Middle East; and Africa.
North America enjoys the leading position due to high healthcare expenditure, advanced medical infrastructure, extensive adoption of innovative PAD treatments, and a growing elderly population prone to PAD-related conditions.
Global Peripheral Artery Disease Market Trends:
Innovations in medical devices, like drug-eluting stents and minimally invasive procedures, are boosting treatment success and patient outcomes for PAD. The increasing elderly population worldwide is raising PAD prevalence, which drives demand for diagnostics and therapies. There’s a strong focus on early detection and prevention strategies for PAD. These include lifestyle changes and screening programs that aim to slow disease progression. In developing regions, awareness is growing. Improved healthcare infrastructure and rising incomes are giving more people access to PAD treatments and creating new market opportunities.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145